Literature DB >> 23461073

Health-related quality of life does not predict mortality in idiopathic pulmonary fibrosis.

O Nishiyama1, H Taniguchi, Y Kondoh, T Kimura, K Kataoka, K Nishimura, T Ogawa, F Watanabe, S Arizono, Y Tohda.   

Abstract

BACKGROUND: Although health-related quality of life (HRQL) has recently been considered to be an important outcome in clinical trials of idiopathic pulmonary fibrosis (IPF), its relationship with survival is unknown.
OBJECTIVE: To determine the prognostic significance of HRQL scores in IPF assessed with the SGRQ.
DESIGN: Eighty-seven consecutive patients with IPF, who had undergone evaluations and completed the St. George's Respiratory Questionnaire (SGRQ) at diagnosis were included in this study, as is the general practice. Cox proportional hazards analyses were performed to examine the relationship between HRQL scores and survival.
RESULTS: The mean observation period was 44.2 +/- 29.6 mo, in the course of which 54 patients (62.0%) died. Univariate analysis revealed that the activity scores in the SGRQ(HR: 1.016, 95% CI: 1.004-1.029, P = 0.01) were significantly predictive of survival, although the symptoms, impacts, and total scores were not significantly related to mortality from all causes. However, multivariate analysis revealed that only the forced vital capacity percent predicted was a significant predictor of survival, and that the activity score in the SGRQwas not significantly related to mortality.
CONCLUSIONS: There was no significant relationship between HRQL evaluated with the SGRQ and the subsequent mortality in IPF. The present negative result might suggest that HRQL is measuring an aspect other than one from physiological and functional impairment or disability.

Entities:  

Mesh:

Year:  2012        PMID: 23461073

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN: 1124-0490            Impact factor:   0.670


  7 in total

1.  Association between physical and mental health-related quality of life and adverse outcomes; a retrospective cohort study of 5,272 Scottish adults.

Authors:  Zia Ul-Haq; Daniel F Mackay; Jill P Pell
Journal:  BMC Public Health       Date:  2014-11-21       Impact factor: 3.295

2.  The St. George's Respiratory Questionnaire as a prognostic factor in IPF.

Authors:  Taiki Furukawa; Hiroyuki Taniguchi; Masahiko Ando; Yasuhiro Kondoh; Kensuke Kataoka; Osamu Nishiyama; Takeshi Johkoh; Junya Fukuoka; Koji Sakamoto; Yoshinori Hasegawa
Journal:  Respir Res       Date:  2017-01-17

3.  The Burden of Illness of Idiopathic Pulmonary Fibrosis: A Comprehensive Evidence Review.

Authors:  Alex Diamantopoulos; Emily Wright; Katerina Vlahopoulou; Laura Cornic; Nils Schoof; Toby M Maher
Journal:  Pharmacoeconomics       Date:  2018-07       Impact factor: 4.981

4.  The association between health-related quality of life and disease progression in idiopathic pulmonary fibrosis: a prospective cohort study.

Authors:  Sokai Akihiko; Handa Tomohiro; Oga Toru; Tanizawa Kiminobu; Ikezoe Kohei; Nakatsuka Yoshinari; Kubo Takeshi; Kanatani Kumiko; Chin Kazuo; Mishima Michiaki
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-03-09       Impact factor: 0.670

5.  Validation of a derived version of the IPF-specific Saint George's Respiratory Questionnaire.

Authors:  Thomas Skovhus Prior; Nils Hoyer; Saher Burhan Shaker; Jesper Rømhild Davidsen; Ole Hilberg; Haridarshan Patel; Elisabeth Bendstrup
Journal:  Respir Res       Date:  2021-10-05

6.  Quality of Life and Healthcare Resource Use in a Real-world Patient Population with Idiopathic Pulmonary Fibrosis: The PROOF Registry.

Authors:  Wim A Wuyts; Caroline Dahlqvist; Hans Slabbynck; Marc Schlesser; Natacha Gusbin; Christophe Compere; Sofie Maddens; Shemra Rizzo; Klaus-Uwe Kirchgaessler; Karen Bartley; Benjamin Bondue
Journal:  Pulm Ther       Date:  2022-04-16

Review 7.  A systematic review of literature to evaluate the burden of physical and psychological symptoms and palliative care in patients diagnosed with idiopathic pulmonary fibrosis.

Authors:  M F van Jaarsveld; L Gwyther
Journal:  Afr J Thorac Crit Care Med       Date:  2019-04-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.